Inclusion-Body Myositis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study of Arimoclomol in Inclusion Body Myositis (IBM)
Condition: Inclusion Body MyositisInterventions: Drug: Arimoclomol; Other: PlaceboSponsors: University of Kansas Medical Center; FDA Office of Orphan Products DevelopmentNot yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2016 Category: Research Source Type: clinical trials
Study of Arimoclomol in Inclusion Body Myositis (IBM)
Condition: Inclusion Body MyositisInterventions: Drug: Arimoclomol; Other: PlaceboSponsor: University of Kansas Medical CenterNot yet recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2016 Category: Research Source Type: clinical trials
